Board Meeting

ZYDUS LIFESCIENCES LTD.

NSE : ZYDUSLIFEBSE : 532321ISIN CODE : INE010B01027Industry : Pharmaceuticals & DrugsHouse : Cadila
BSE930.80-5.5 (-0.59 %)
PREV CLOSE ( ) 936.30
OPEN PRICE ( ) 929.30
BID PRICE (QTY) 929.80 (41)
OFFER PRICE (QTY) 930.45 (64)
VOLUME 6885
TODAY'S LOW / HIGH ( )916.55 931.70
52 WK LOW / HIGH ( )482.55 1031.3
NSE928.45-8.55 (-0.91 %)
PREV CLOSE( ) 937.00
OPEN PRICE ( ) 920.25
BID PRICE (QTY) 928.30 (7)
OFFER PRICE (QTY) 928.45 (3)
VOLUME 224897
TODAY'S LOW / HIGH( ) 915.85 931.50
52 WK LOW / HIGH ( )484.95 1031.7

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.